Solasia Pharma K.K. — Investor Relations & Filings
Solasia Pharma K.K. is a specialty pharmaceutical company focused on oncology. The company's business model involves in-licensing promising drug candidates to develop and commercialize them for patients in Asian markets. Its portfolio is centered on addressing unmet medical needs in both cancer treatment and supportive care, aiming to improve patients' quality of life. Key commercialized products include Sancuso® for chemotherapy-induced nausea and vomiting (CINV), DARVIAS® for peripheral T-cell lymphoma (PTCL), and episil® oral liquid, a medical device for pain associated with oral mucositis. The development pipeline includes candidates for treating chemotherapy-induced peripheral neuropathy (CIPN) and colorectal cancer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 四半期報告書－第15期第3四半期(令和4年7月1日－令和4年9月30日) | 2022-11-14 | Japanese | |
| 確認書 | 2022-08-18 | Japanese | |
| 訂正四半期報告書－第15期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-18 | Japanese | |
| 四半期報告書－第15期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-15 | Japanese | |
| 確認書 | 2022-08-15 | Japanese | |
| 四半期報告書－第15期第1四半期(令和4年1月1日－令和4年3月31日) | 2022-05-13 | Japanese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
9 filings
| |||||
| 7583273 | 四半期報告書－第15期第3四半期(令和4年7月1日－令和4年9月30日) | 2022-11-14 | Japanese | ||
| 7590307 | 確認書 | 2022-08-18 | Japanese | ||
| 7590309 | 訂正四半期報告書－第15期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-18 | Japanese | ||
| 7590641 | 四半期報告書－第15期第2四半期(令和4年4月1日－令和4年6月30日) | 2022-08-15 | Japanese | ||
| 7590639 | 確認書 | 2022-08-15 | Japanese | ||
| 7609494 | 四半期報告書－第15期第1四半期(令和4年1月1日－令和4年3月31日) | 2022-05-13 | Japanese | ||
| 7614166 | 確認書 | 2022-03-24 | Japanese | ||
| 7614160 | 内部統制報告書－第14期(令和3年1月1日－令和3年12月31日) | 2022-03-24 | Japanese | ||
| 7614168 | 有価証券報告書－第14期(令和3年1月1日－令和3年12月31日) | 2022-03-24 | Japanese | ||
|
2021
6 filings
| |||||
| 7624312 | 四半期報告書－第14期第3四半期(令和3年7月1日－令和3年9月30日) | 2021-11-10 | Japanese | ||
| 7628625 | 四半期報告書－第14期第2四半期(令和3年4月1日－令和3年6月30日) | 2021-08-11 | Japanese | ||
| 7672346 | 四半期報告書－第14期第1四半期(令和3年1月1日－令和3年3月31日) | 2021-05-12 | Japanese | ||
| 7673839 | 確認書 | 2021-03-29 | Japanese | ||
| 7673842 | 有価証券報告書－第13期(令和2年1月1日－令和2年12月31日) | 2021-03-29 | Japanese | ||
| 7673838 | 内部統制報告書－第13期(令和2年1月1日－令和2年12月31日) | 2021-03-29 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Solasia Pharma K.K. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14027/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14027 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14027 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14027 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14027}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Solasia Pharma K.K. (id: 14027)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.